- Drug Pipelines
- March 2022
- 900 Pages
Global
From €8142EUR$9,000USD£6,972GBP
- Report
- September 2023
- 270 Pages
Global
From €2216EUR$2,450USD£1,898GBP
- Report
- December 2022
- 260 Pages
Global
From €2171EUR$2,400USD£1,859GBP
- Report
- January 2025
- 165 Pages
Global
From €4207EUR$4,650USD£3,602GBP
- Report
- June 2023
- 186 Pages
Global
From €4207EUR$4,650USD£3,602GBP
- Report
- February 2023
- 287 Pages
Global
From €2262EUR$2,500USD£1,937GBP
- Report
- December 2022
- 93 Pages
Global
From €4976EUR$5,500USD£4,261GBP
- Report
- February 2022
- 157 Pages
Global
From €4976EUR$5,500USD£4,261GBP
- Report
- March 2021
- 216 Pages
Global
From €2488EUR$2,750USD£2,130GBP
- Report
- October 2023
- 305 Pages
Global
From €3800EUR$4,200USD£3,254GBP
- Report
- April 2022
- 302 Pages
Global
From €3392EUR$3,750USD£2,905GBP
- Report
- April 2024
- 100 Pages
Global
From €5383EUR$5,950USD£4,609GBP
- Report
- May 2025
- 200 Pages
Global
From €2253EUR$2,490USD£1,929GBP
- Report
- July 2018
- 108 Pages
Global
From €1348EUR$1,490USD£1,154GBP
- Report
- February 2025
- 316 Pages
Global
From €4071EUR$4,500USD£3,486GBP
- Report
- June 2025
- 150 Pages
Global
From €3618EUR$3,999USD£3,098GBP
- Report
- April 2025
- 120 Pages
United States
From €4433EUR$4,900USD£3,796GBP
- Report
- April 2025
Asia Pacific
From €4433EUR$4,900USD£3,796GBP
- Report
- April 2025
Global
From €4433EUR$4,900USD£3,796GBP
- Report
- July 2024
- 70 Pages
Europe
From €2669EUR$2,950USD£2,285GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more